[
    [
        {
            "time": "2021-07",
            "original_text": "2021年1-7月，CDE-2类新药承办概述",
            "features": {
                "keywords": [
                    "CDE",
                    "2类新药",
                    "承办"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "2021年1-7月，CDE-2类新药承办概述",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 5,
                "Source_Recency": 3
            }
        },
        {
            "time": "2021",
            "original_text": "【安信医药】新药周观点：2021年内预计将共有5款新PD-1/PD-L1单抗在国内获批上市",
            "features": {
                "keywords": [
                    "安信医药",
                    "PD-1",
                    "PD-L1",
                    "单抗",
                    "获批上市"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【安信医药】新药周观点：2021年内预计将共有5款新PD-1/PD-L1单抗在国内获批上市",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "current",
            "original_text": "中泰医药行业周报：疫情、中报成为当前催化 把握医药行业投资窗口",
            "features": {
                "keywords": [
                    "中泰医药",
                    "疫情",
                    "中报",
                    "投资窗口"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中泰医药行业周报：疫情、中报成为当前催化 把握医药行业投资窗口",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]